{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T07:42:09Z","timestamp":1790667729786,"version":"4.1.0"},"reference-count":28,"publisher":"Cambridge University Press (CUP)","license":[{"start":{"date-parts":[[2019,3,21]],"date-time":"2019-03-21T00:00:00Z","timestamp":1553126400000},"content-version":"unspecified","delay-in-days":79,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Epidemiol. Infect."],"published-print":{"date-parts":[[2019]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Making a distinction between facial palsy due to Lyme neuroborreliosis (LNB) and idiopathic facial palsy (IFP) is of importance to ensure timely and adequate treatment. The study objective was to assess incidence and patient characteristics of facial palsy due to LNB. Hospital records were reviewed of adult patients with facial palsy visiting the departments of neurology and\/or otorhinolaryngology of Gelre hospitals between June 2007 and December 2017. Gelre hospitals are located in an area endemic for Lyme borreliosis. Patients with LNB had pleocytosis and intrathecal antibody production or pleocytosis with positive IgG serology. Patients with IFP had negative serology. Clinical characteristics were compared between patients with LNB and patients with IFP. Five hundred and fifty-nine patients presented with facial palsy, 4.7% (26) had LNB and 39.4% (220) IFP. The incidence of facial palsy due to LNB was 0.9\/100 000 inhabitants\/year. Over 70% of patients with facial palsy due to LNB did not report a recent tick bite and\/or erythema migrans (EM). Patients with facial palsy due to LNB presented more often in July to September (69.2% <jats:italic>vs.<\/jats:italic> 21.9%, <jats:italic>P<\/jats:italic> &lt; 0.001), and had more often headache (42.3% <jats:italic>vs.<\/jats:italic> 15.5%, <jats:italic>P<\/jats:italic> &lt; 0.01). To reduce the risk of underdiagnosing LNB in an endemic area, we recommend testing for LNB in patients with facial palsy in summer months especially when presenting with headache, irrespective of a recent tick bite and\/or EM.<\/jats:p>","DOI":"10.1017\/s0950268819000438","type":"journal-article","created":{"date-parts":[[2019,3,21]],"date-time":"2019-03-21T06:12:33Z","timestamp":1553148753000},"source":"Crossref","is-referenced-by-count":18,"title":["Incidence and characteristics of Lyme neuroborreliosis in adult patients with facial palsy in an endemic area in the Netherlands"],"prefix":"10.1017","volume":"147","author":[{"given":"S.M.","family":"Bierman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"van Kooten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.M.","family":"Vermeeren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.D.","family":"Bruintjes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.C.","family":"van Hees","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.A.","family":"Bruinsma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.W.","family":"Landman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"van Bemmel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8412-4101","authenticated-orcid":false,"given":"T.P.","family":"Zomer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"56","published-online":{"date-parts":[[2019,3,21]]},"reference":[{"key":"S0950268819000438_ref28","first-page":"1","article-title":"Surveillance for Lyme disease \u2013 United States, 2008\u20132015","volume":"66","author":"Schwartz","year":"2017","journal-title":"Morbidity and Mortality Weekly Report. Surveillance Summaries"},{"key":"S0950268819000438_ref26","doi-asserted-by":"publisher","DOI":"10.1186\/s13071-015-0777-6"},{"key":"S0950268819000438_ref22","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0404.1991.tb03959.x"},{"key":"S0950268819000438_ref21","doi-asserted-by":"publisher","DOI":"10.1002\/lary.24542"},{"key":"S0950268819000438_ref17","doi-asserted-by":"publisher","DOI":"10.1186\/s12887-018-1163-2"},{"key":"S0950268819000438_ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-007-0445-7"},{"key":"S0950268819000438_ref14","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-016-3105-y"},{"key":"S0950268819000438_ref13","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-11-215"},{"key":"S0950268819000438_ref12","first-page":"125","article-title":"Lyme borreliosis and facial paralysis \u2013 a prospective analysis of risk factors and outcome","volume":"23","author":"Peltomaa","year":"2002","journal-title":"American Journal of Otolaryngology \u2013 Head and Neck Medicine and Surgery"},{"key":"S0950268819000438_ref8","doi-asserted-by":"publisher","DOI":"10.1002\/lary.26273"},{"key":"S0950268819000438_ref19","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-005-0715-1"},{"key":"S0950268819000438_ref18","unstructured":"OXOID IDEIA Lyme Neuroborreliosis. Available at https:\/\/www.thermofisher.com\/search\/results?persona=DocSupport&refinementSearch=true&query=Manuals+&+Protocols&navId=4294959596&refinementQuery=IDEIA+Lyme+neuroborreliosis (Accessed 4 July 2018 )."},{"key":"S0950268819000438_ref3","first-page":"195","article-title":"Peripheral facial weakness (Bell's palsy)","volume":"52","author":"Ba\u0161i\u0107-Kes","year":"2013","journal-title":"Acta Clinica Croatica"},{"key":"S0950268819000438_ref25","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2008-1273"},{"key":"S0950268819000438_ref20","doi-asserted-by":"publisher","DOI":"10.1007\/s00508-014-0685-3"},{"key":"S0950268819000438_ref5","unstructured":"Dutch Quality Institute for Health Care (CBO) (2009) Dutch national guideline for idiopathic peripheral facial palsy. Available at https:\/\/www.nvmka.nl\/sites\/www.nvmka.nl\/files\/Richtlijn-Idiopathische-Perifere-Aangezichtsverlamming-IPAV.pdf (Accessed 3 July 2018 )."},{"key":"S0950268819000438_ref11","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.2007.01799.x"},{"key":"S0950268819000438_ref4","doi-asserted-by":"crossref","first-page":"83","DOI":"10.12659\/MSM.889876","article-title":"The neurologist's dilemma: a comprehensive clinical review of Bell's palsy, with emphasis on current management trends","volume":"20","author":"Zandian","year":"2014","journal-title":"Medical Science Monitor"},{"key":"S0950268819000438_ref7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.2009.02862.x"},{"key":"S0950268819000438_ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)60103-7"},{"key":"S0950268819000438_ref24","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e3181bbf28a"},{"key":"S0950268819000438_ref16","unstructured":"Mikrogen Diagnostik (2013) Mikrogen Diagnostik, recomLine Borrelia, Instructions for use. Available at https:\/\/www.mikrogen.de\/english\/products\/product-overview\/weitereinfo\/borrelia-igg-1.html (Accessed 4 July 2018)."},{"key":"S0950268819000438_ref2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2010.03175.x"},{"key":"S0950268819000438_ref10","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-016-1468-4"},{"key":"S0950268819000438_ref9","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cix568"},{"key":"S0950268819000438_ref27","first-page":"148","article-title":"Klinisch spectrum en incidentie van neuroborreliose in Nederland","volume":"3","author":"Kuiper","year":"2004","journal-title":"Nederlands Tijdschrift voor Geneeskunde"},{"key":"S0950268819000438_ref23","doi-asserted-by":"publisher","DOI":"10.1080\/00365540601105764"},{"key":"S0950268819000438_ref6","unstructured":"Dutch Quality Institute for Health Care (CBO) (2013) Dutch national guideline for Lyme borreliosis. Available at https:\/\/www.rivm.nl\/sites\/default\/files\/2018-11\/CBO%20richtlijn%20Lymeziekte%20definitief%20juli%202013.pdf (Accessed 3 July 2018)."}],"container-title":["Epidemiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0950268819000438","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,7]],"date-time":"2019-06-07T17:53:15Z","timestamp":1559929995000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0950268819000438\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":28,"alternative-id":["S0950268819000438"],"URL":"https:\/\/doi.org\/10.1017\/s0950268819000438","relation":{},"ISSN":["0950-2688","1469-4409"],"issn-type":[{"value":"0950-2688","type":"print"},{"value":"1469-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019]]},"article-number":"e160"}}